Megan Brooks Using a mobile phone to make or receive calls for just 30 minutes a week is associated with an increased risk of developing hypertension, a large observational study using UK Biobank data suggests. The study showed adults who spent that at least a half-hour per week on their mobile phone had a 12% increased risk of developing hypertension, whereas those who spent more than 6 hours weekly had a 25% increased risk, compared with a weekly usage time of under 5 minutes. The investigators caution, however, that the results are purely “hypothesis-generating” and require confirmation, the researchers say. Experts not involved in the study also urged caution in interpreting the results. “This study should not be considered a basis to recommend reducing time spent using mobile phones to make calls as a technique to avoid hypertension,” Matthew Tomey, MD, cardiologist, Icahn School of Medicine at Mount Sinai in New ...
The US Food and Drug Administration (FDA) has issued new draft guidance on the implementation of decentralised clinical trials (DCTs), in which some or all trial-related activities occur at locations other than traditional investigation sites. This could include carrying out clinical tests at a local facility rather than a research medical centre, or conducting follow-up visits in the participants’ homes using telemedicine. The 16-page document provides recommendations for sponsors, investigators and other stakeholders on the use of these trials, which the agency expects’ will play an important role in addressing public health needs’. ‘By reducing barriers to participation, we expect that DCTs will increase the breadth and diversity of participants in clinical trials and improve accessibility for those with rare diseases or mobility challenges,’ the FDA said in a statement. The guidance covers recommendations on topics such as DCT design, the use of digital health technologies for remote patient monitoring, ...
By Neha Mathur In a recent study published in JAMA Internal Medicine, researchers evaluated the ability of ChatGPT, an artificial intelligence-based chatbot assistant, to respond to patient questions posted on a publically accessible social media forum. Background Owing to the quick expansion of digital health care, more and more patients have begun to raise queries on social media forums. Answering these questions is not just time-consuming but tedious for healthcare professionals. AI assistants, like ChatGPT, could help address this additional work and help draft quality responses, which later clinicians could review. About the study In the present cross-sectional study, researchers randomly drew 195 exchanges in response to a patient question asked over Reddit’s r/AskDocs, a publically accessible social media forum, in October 2022. Then, a team of licensed healthcare professionals generated a new chatbot session using the original full text of the question to which a physician responded and then evaluated the ...
The team developed a deep learning AI model that can identify which at-risk infants have ROP that may lead to blindness if left untreated, and they hope their technique could improve access to screening in the many areas with limited neonatal services and few trained ophthalmologists. The study, by an international team of scientists and clinicians in the UK, Brazil, Egypt and the US, supported by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, is published in The Lancet Digital Health. Lead author Dr. Konstantinos Balaskas (Director, Moorfields Ophthalmic Reading Centre & Clinical AI Lab, Moorfields Eye Hospital and Associate Professor, UCL Institute of Ophthalmology) said, “Retinopathy of prematurity is becoming increasingly common as survival rates of premature babies improve across the globe, and it is now the leading cause of childhood blindness in ...
Can we really call ourselves patient-centric if we don’t embrace personalization? In a world where consumers can order a customized latte, stream a personalized playlist, and get tailored fashion recommendations with a few clicks, it’s no wonder that patients are increasingly demanding that same level of personalization from the pharmaceutical companies that provide them with life-changing medications. In comparison to other industries, such as retail and banking, pharma is still considered to be somewhat behind in delivering on this patient expectation. This has been largely due to a lack of data integration across the ecosystem, disparate access to digital technologies, and regulatory constraints. However, the industry is well poised to overcome these challenges because of two major forces. The first is the democratization of information, providing access to data to power personalization; 63% of patients would be willing to share their data with pharma companies for greater personalization.1 The ...
Thrive, a wellbeing approved for use by the NHS, has raising a total of £2.5m in funding in only ten days, the digital health company has announced. The latest funding round attracted investment from the Sumerian Foundation and Treebeard Trust, as well as from investment platforms such as Syndicate Room and Wealth Club. In a statement, Thrive said it would use the new funding to research and identify further areas of help that it can support and also develop the tech platform further. This will include increased integration with existing medical data, with the aim of giving users ‘seamless’ access to mental health care. Currently, the app provides whole-person solutions for workplaces and individuals, and is designed to help users overcome periods of stress while supporting long-term mental health. It uses clinical-grade, evidence-based techniques to achieve this, while also providing in-app access to trained therapists. The company was initially launched ...
By HospiMedica International staff writers Posted on 31 Aug 2020 Contract tracing apps used to reduce the spread of COVID-19 are unlikely to be effective without proper uptake and support from concurrent control measures, according to a new study. Researchers at University College London (UCL, United Kingdom) conducted a systematic review of studies that examined the use of automated or partly automated contact tracing of COVID-19, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, or Ebola virus spread. The primary outcomes were the number or proportion of subsequent contacts identified; secondary outcomes included indicators of outbreak control, uptake, resource use, cost-effectiveness, and lessons learnt. In all, 4,033 papers were reviewed, of which 15 were identified with useful data. The results showed no empirical evidence of the effectiveness of automated contact tracing. Four of the seven studies suggested that to control COVID-19, high population uptake of automated contact-tracing ...
Mike Bolduc, global marketing manager at C&K, once stated that since the market growth in terms of wearable medical devices wholesale reached $4 billion in 2017, it is expected to increase by 35 percent by 2019.
The demand for novel medical technologies seems to grow continuously. Hence there has been an increasing number of start-ups in order to fill the gaps by providing innovative solutions to persisting health issues. In this article, we will have a brief look at five of the world’s most promising medical device start-ups.
Astronauts at the International Space Station are dependent upon telemedicine for all kinds of illness. However, according to Dr. Shannan Moynihan, the deputy chief of space and occupational medicine from the NASA Johnson Space Centre, although effective, telemedicine has its limits.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.